Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA approves new agent for multiple myeloma.

× No keyword cloud information.

16 in total

Review 1. Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.

Authors: Christopher Foley; Nicholas Mitsiades
Journal: Horm Cancer Date: 2016-01-04 Impact factor: 3.869

2. Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.

Authors: Samuel Bouchet; Camille Linot; Dusan Ruzic; Danica Agbaba; Benoit Fouchaq; Joëlle Roche; Katarina Nikolic; Christophe Blanquart; Philippe Bertrand
Journal: ACS Med Chem Lett Date: 2019-05-09 Impact factor: 4.345

3. ATF3 Repression of BCL-X_L Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types.

Authors: Anderly C Chüeh; Janson W T Tse; Michael Dickinson; Paul Ioannidis; Laura Jenkins; Lars Togel; BeeShin Tan; Ian Luk; Mercedes Davalos-Salas; Rebecca Nightingale; Matthew R Thompson; Bryan R G Williams; Guillaume Lessene; Erinna F Lee; Walter D Fairlie; Amardeep S Dhillon; John M Mariadason
Journal: Clin Cancer Res Date: 2017-06-13 Impact factor: 12.531

Review 4. Metal-dependent Deacetylases: Cancer and Epigenetic Regulators.

Authors: Jeffrey E López; Eric D Sullivan; Carol A Fierke
Journal: ACS Chem Biol Date: 2016-03-18 Impact factor: 5.100

5. HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides.

Authors: Carol Ann Castañeda; Noah A Wolfson; Katherine R Leng; Yin-Ming Kuo; Andrew J Andrews; Carol A Fierke
Journal: J Biol Chem Date: 2017-11-06 Impact factor: 5.157

6. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.

Authors: Katherine B Schuetze; Matthew S Stratton; Weston W Blakeslee; Michael F Wempe; Florence F Wagner; Edward B Holson; Yin-Ming Kuo; Andrew J Andrews; Tonya M Gilbert; Jacob M Hooker; Timothy A McKinsey
Journal: J Pharmacol Exp Ther Date: 2017-02-07 Impact factor: 4.030

7. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.

Authors: Alexa A Tabackman; Rochelle Frankson; Eric S Marsan; Kay Perry; Kathryn E Cole
Journal: J Struct Biol Date: 2016-06-29 Impact factor: 2.867

8. Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy.

Authors: Fatima El Bahhaj; Iza Denis; Loic Pichavant; Régis Delatouche; Floraine Collette; Camille Linot; Daniel Pouliquen; Marc Grégoire; Valérie Héroguez; Christophe Blanquart; Philippe Bertrand
Journal: Theranostics Date: 2016-03-25 Impact factor: 11.556

Review 9. Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.

Authors: Antonia Cagnetta; Davide Lovera; Raffaella Grasso; Nicoletta Colombo; Letizia Canepa; Filippo Ballerini; Marino Calvio; Maurizio Miglino; Marco Gobbi; Roberto Lemoli; Michele Cea
Journal: Biomed Res Int Date: 2015-10-22 Impact factor: 3.411

10. The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and Autophagy.

Authors: Birgit Lohberger; Bibiane Steinecker-Frohnwieser; Nicole Stuendl; Heike Kaltenegger; Andreas Leithner; Beate Rinner
Journal: PLoS One Date: 2016-12-15 Impact factor: 3.240